2,638
Views
27
CrossRef citations to date
0
Altmetric
Research Article

Genomic Insights Into Nitrofurantoin Resistance Mechanisms and Epidemiology in Clinical Enterobacteriaceae

Article: FSO293 | Received 27 Nov 2017, Accepted 23 Jan 2018, Published online: 27 Feb 2018

References

  • Osei Sekyere J, Govinden U, Essack YS. Review of established and innovative detection methods for carbapenemase-producing Gram-negative bacteria. J. Appl. Microbiol. 119(5), 1219–1233 (2015).
  • Osei Sekyere J, Govinden U, Bester LA, Essack SY. Colistin and tigecycline resistance in carbapenemase-producing Gram-negative bacteria: emerging resistance mechanisms and detection methods. J. Appl. Microbiol. 121(3), 601–617 (2016).
  • Osei Sekyere J, Govinden U, Essack S. The molecular epidemiology and genetic environment of carbapenemases detected in Africa. Microb. Drug Resist. 22(1), 59–68 (2015).
  • Osei Sekyere J. Current state of resistance to antibiotics of last-resort in South Africa: a review from a public health perspective. Front. Public Health 4, 209 (2016).
  • Osei Sekyere J, Amoako DG. Carbonyl cyanide m-chlorophenylhydrazine (CCCP) reverses resistance to colistin, but not to carbapenems and tigecycline in multidrug-resistant Enterobacteriacea. Front. Microbiol. 8, 228 (2017).
  • Livermore DM, Warner M, Mushtaq S, Doumith M, Zhang J, Woodford N. What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecyclin. Int. J. Antimicrob. Agents 37(5), 415–419 (2011).
  • Nordmann P, Poirel L, Walsh TR, Livermore DM. The emerging NDM carbapenemases. Trends Microbiol. 19(12), 588–595 (2011).
  • Matthews PC, Barrett LK, Warren S et al. Oral fosfomycin for treatment of urinary tract infection: a retrospective cohort study. BMC Infect. Dis. 16(1), 556 (2016).
  • Cassir N, Rolain J-M, Brouqui P. A new strategy to fight antimicrobial resistance: the revival of old antibiotics. Front. Microbiol. 5, 551 (2014).
  • Mediavilla JRJR, Patrawalla A, Chen L et al. Colistin- and carbapenem-resistant Escherichia coli harboring mcr-1 and blaNDM-5, causing a complicated urinary tract infection in a patient from the United States. MBio 7(4), 5–8 (2016).
  • Poirel L, Benouda A, Hays C, Nordmann P. Emergence of NDM-1-producing Klebsiella pneumoniae in Morocco. J. Antimicrob. Chemother. 66, 2781–2783 (2011).
  • Bandow JE, Brötz H, Leichert LIO, Labischinski H, Hecker M. Proteomic approach to understanding antibiotic action. Antimicrob. Agents Chemother. 47(3), 948–955 (2003).
  • Shakti L, Veeraraghavan B. Advantage and limitations of nitrofurantoin in multidrug resistant Indian scenario. Indian J. Med. Microbiol. 33(4), 477–481 (2015).
  • Vervoort J, Xavier B, Stewardson A, Coenen S, Godycki-cwirko M, Adriaenssens N. An In vitro deletion in ribE encoding lumazine synthase contributes to nitrofurantoin resistance in Escherichia coli. Antimicrob. Agents Chemother. 58(12), 7225–7233 (2014).
  • Osei Sekyere J, Asante J. Emerging mechanisms of antimicrobial resistance in bacteria and fungi: advances in the era of genomics. Future Microbiol. 13(2), 1–22 (2018).
  • Ho P, Ng K, Lo W et al. Plasmid-mediated oqxAB is an important mechanism for nitrofurantoin resistance in Escherichia coli. Antimicrob. Agents Chemother. 60(1), 537–543 (2016).
  • Osei Sekyere J, Amoako DG. Genomic and phenotypic characterisation of fluoroquinolone resistance mechanisms in Enterobacteriaceae in Durban, South Africa. PLoS ONE 12(6), 1–14 (2017).
  • Osei Sekyere J, Govinden U, Essack SY. Comparison of existing phenotypic and genotypic tests for the detection of NDM and GES carbapenemase-producing Enterobacteriacea. J. Pure Appl. Microbiol. 10(4), 2585–2591 (2016).
  • Center for Genomic Epidemiology. SPAdes 3.9 server. https://cge.cbs.dtu.dk/services/SPAdes/.
  • Center for Genomic Epidemiology. ResFinder 3.0 server. https://cge.cbs.dtu.dk/services/ResFinder/.
  • The Comprehensive Antibiotic Resistance Database (CARD). Resistance Gene Identifier. https://card.mcmaster.ca/analyze/rgi.
  • NCBI. Prokaryotic Genome Annotation Pipeline. www.ncbi.nlm.nih.gov/genome/annotation_prok/.
  • PATRIC. www.patricbrc.org/.
  • BioEdit. Sequence Alignment Editor. www.mbio.ncsu.edu/BioEdit/bioedit.html.
  • Center for Genomic Epidemiology. CSI Phylogeny 1.4 server. https://cge.cbs.dtu.dk/services/CSIPhylogeny/.
  • Parsnp. http://harvest.readthedocs.io/en/latest/content/parsnp/quickstart.html.
  • Gingr. https://harvest.readthedocs.io/en/latest/content/gingr.html.
  • FigTree. http://tree.bio.ed.ac.uk/software/figtree/.
  • Molecular Evolutionary Genetics Analysis (MEGA). www.megasoftware.net/megaccbetausage.php.
  • Hadfield J, Croucher NJ, Goater RJ, Abudahab K, Aanensen DM, Harris SR. Phandango: an interactive viewer for bacterial population genomics. Bioinformatics 34(2), 292–293 (2017).
  • Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing; twenty-seventh informational supplement M100-S27. CLSI, Wayne, PA, USA (2017).www.facm.ucl.ac.be/intranet/CLSI/CLSI-2017-M100-S27.pdf.
  • Shaikh N, Hoberman A, Keren R et al. Predictors of antimicrobial resistance among pathogens causing urinary tract infection in children. J. Pediat. 171, 116–121 (2016).
  • Cunha BA, Schoch PE, Hage JR. Nitrofurantoin: preferred empiric therapy for community-acquired lower urinary tract infections. Mayo Clin. Proc. 86(12), 1243–1244 (2011).
  • Habte TM, Dube S, Ismail N, Hoosen AA. Hospital and community isolates of uropathogens at a tertiary hospital in South Africa. S. Afr. Med. J. 99(8), 584–587 (2009).
  • Lewis DA, Gumede LYE, van der Hoven LA et al. Antimicrobial susceptibility of organisms causing community-acquired urinary tract infections in Gauteng Province, South Africa. S. Afr. Med. J. 103(6), 377–381 (2013).
  • Abia ALK, Ubomba-Jaswa E, Momba MNB. High prevalence of multiple-antibiotic-resistant (MAR) Escherichia coli in river bed sediments of the Apies River, South Africa. Environ. Monit. Assess. 187(10), 652 (2015).
  • Okoche D, Asiimwe BB, Katabazi FA, Kato L, Najjuka CF. Prevalence and characterization of carbapenem-resistant Enterobacteriaceae isolated from Mulago National Referral Hospital, Uganda. PLoS ONE 10(8), e0135745 (2015).
  • Bryce A, Hay AD, Lane IF, Thornton HV, Wootton M, Costelloe C. Global prevalence of antibiotic resistance in pediatric urinary tract infections caused by Escherichia coli and association with routine use of antibiotics in primary care: systematic review and meta-analysis. BMJ 2016, 352 (2016).
  • Huttner A, Verhaegh EM, Harbarth S, Muller AE, Theuretzbacher U, Mouton JW. Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials. J. Antimicrob. Chemother. 70(9), 2456–2464 (2015).
  • Mlynarczyk A, Mlynarczyk G, Pupek J et al. Serratia marcescens isolated in 2005 from clinical specimens from patients with diminished immunity. Transpl. Proc. 39(9), 2879–2882 (2007).
  • Brink AJ, Coetzee J, Corcoran C et al. Emergence of OXA-48 and OXA-181 carbapenemases among Enterobacteriaceae in South Africa and evidence of in vivo selection of colistin resistance as a consequence of selective decontamination of the gastrointestinal tract. J. Clin. Microbiol. 51(1), 369–372 (2013).
  • Papadimitriou-Olivgeris M, Marangos M, Fligou F et al. KPC-producing Klebsiella pneumoniae enteric colonization acquired during intensive care unit stay: the significance of risk factors for its development and its impact on mortality. Diagn. Microbiol. Infect. Dis. 77(2), 169–173 (2013).
  • D'Arezzo S, Principe L, Capone A, Petrosillo N, Petrucca A, Visca P. Changing carbapenemase gene pattern in an epidemic multidrug-resistant Acinetobacter baumannii lineage causing multiple outbreaks in central Italy. J. Antimicrob. Chemother. 66(1), 54–61 (2011).
  • Vervoort J, Xavier BB, Stewardson A et al. An in vitro deletion in ribE encoding lumazine synthase contributes to nitrofurantoin resistance in Escherichia coli. Antimicrob. Agents Chemother. 58(12), 7225–7233 (2014).
  • Vervoort J, Xavier BB, Stewardson A et al. Metagenomic analysis of the impact of nitrofurantoin treatment on the human fecal microbiota. J. Antimicrob. Chemother. 70(7), 1989–1992 (2015).
  • Park YK, Ko KS. Effect of carbonyl cyanide 3-chlorophenylhydrazone (CCCP) on killing Acinetobacter baumannii by colistin J. Microbiol. 53(1), 53–59 (2015).
  • Veleba M, De Majumdar S, Hornsey M, Woodford N, Schneiders T. Genetic characterization of tigecycline resistance in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes. J. Antimicrob. Chemother. 68(5), 1011–1018 (2013).
  • Sandegren L, Lindqvist A, Kahlmeter G. Andersson DNitrofurantoin resistance mechanism and fitness cost in Escherichia coli. J. Antimicrob. Chemother. 62(3), 495–503 (2008).